Loading...
By the Editors
This week, U.S. health officials urged state governors to expand COVID-19 vaccination to all adults aged 65 and older and to those 18 and older with certain medical comorbidities. In addition, we reported promising findings on the Pfizer-BioNTech vaccine: in an in vitro study, serum from people who'd received two doses of vaccine neutralized SARS-CoV-2 carrying N501Y — a mutation found in some highly contagious variants. Elsewhere, early safety and immunogenicity findings for Johnson & Johnson's vaccine were published in the New England Journal of Medicine. And, finally, a study found that home quarantine was associated with a striking increase in myopia in younger school-aged children. Catch up on these and all of our COVID-19 stories from the past week at the links below.
Comment
LINK(S):
COVID-19: Home Quarantine Linked to Increase in Myopia Among Younger Children (Jan. 14) (Free)
COVID-19: Single Dose of J&J Vaccine / Plasma / New Testing Requirement (Jan. 13) (Free)
COVID-19: Officials Urge Expanding Vaccination / Infected Gorillas / Early Mitigation Strategies (Jan. 12) (Free)
Gut Microbiome Altered in COVID-19 Patients (Jan. 11) (Free)
SARS-CoV-2 Variants: Vaccine Neutralizes Virus with Key Mutation / FDA Warns of Theoretical Risk for False-Negatives (Jan. 10) (Free)
COVID-19: Symptoms at 6 Months / IL-6 Inhibitors / Delirium Risk Factors (Jan. 10) (Free)